Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan

Bunta Yoshimura; Ikuta Shinkawa; Akiko Konishi

首页> 外文期刊>Asian journal of psychiatry >Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan

【24h】

Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan

机译：日本开始使用利培酮长效注射前后精神分裂症患者的住院风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Previous mirror-image studies showed that treatment with risperidone long-acting injection (RLAI) avoids hospitalization in the treatment of schizophrenia (Carswell et al., 2010; Chang et al., 2012; Crivera et al., 2011; Fuller et al., 2009; Girardi et al., 2010; Ren et al., 2011), although there is little evidence that it does in Japanese clinical settings. This study used mirror-image analysis to investigate changes in the hospitalization risk, number of hospitalization and hospitalization days in real-world practice in Japan for patients with schizophrenia 1 year before and 1 year after initiation of RLAI.

机译：先前的镜像研究表明，使用利培酮长效注射液（RLAI）可以避免精神分裂症的住院治疗（Carswell等，2010; Chang等，2012; Crivera等，2011; Fuller等。（2009年; Girardi等人，2010年; Ren等人，2011年），尽管很少有证据表明它在日本的临床环境中起作用。这项研究采用镜像分析方法，调查了在日本，在现实生活中，对于精神分裂症患者，在RLAI开始前1年和1年后，其住院风险，住院天数和住院天数的变化。

著录项

来源
《Asian journal of psychiatry》 |2015年第null期|共2页
作者
Bunta Yoshimura; Ikuta Shinkawa; Akiko Konishi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词

相似文献

外文文献
中文文献
专利

1. Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan [J] . Bunta Yoshimura, Ikuta Shinkawa, Akiko Konishi Asian journal of psychiatry . 2015,第Null期

机译：日本开始使用利培酮长效注射前后精神分裂症患者的住院风险
2. Comparison of hospitalization risk before and after changing from risperidone long-acting injection to another long-acting injection or oral antipsychotic in patients with schizophrenia: Mirror-image study [J] . Suzuki Hidenobu, Hibino Hiroyuki, Inoue Yuichi, Psychiatry and clinical neurosciences . 2016,第7a8期

机译：精神分裂症患者从利培酮长效注射改为另一种长效注射或口服抗精神病药前后的住院风险比较：镜像研究
3. Comparison of hospitalization risk before and after changing from risperidone long-acting injection to another long-acting injection or oral antipsychotic in patients with schizophrenia: Mirror-image study [J] . Suzuki Hidenobu, Hibino Hiroyuki, Inoue Yuichi, Psychiatry and clinical neurosciences . 2016,第7a8期

机译：从肝脏酮长效注射到患有精神分裂症患者的risperidone长效注射前后住院风险的比较：镜像研究
4. A Pharmacogenomic Study on the Polymorphic Gene Response to Risperidone in Schizophrenia Patients [C] . Lei Wang, Daniel OConnor, Ying Wang, IEEE International Conference on Cognitive Informatics . 2008

机译：精神分裂症患者二苯胺酮多态性基因反应的药物替代研究
5. Introducing Risperidone for Treatment of Schizophrenia to the Essential Drug List in Uganda: A Budget Impact Analysis [D] . Liu, Rong. 2017

机译：在乌干达将利培酮引入治疗精神分裂症的基本药物目录：预算影响分析
6. A Post-hoc Comparison of Paliperidone Palmitate to Oral Risperidone During Initiation of Long-acting Risperidone Injection in Patients with Acute Schizophrenia [O] . Srihari Gopal, Gahan Pandina, Rosanne Lane, 2011

机译：急性精神分裂症患者长效利培酮注射液启动期间帕潘立酮棕榈酸酯与口服利培酮的事后比较
7. A study of the efficacy and safety of switching from oral risperidone to risperidone long-acting injection in older patients with schizophrenia [O] . Hidenobu Suzuki, Yuichi Inoue, Keishi Gen 2012

机译：口服氯化酮对老年患者口服酮酮切换到蓖麻精酮的疗效和安全性研究

Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan

摘要

著录项

相似文献

相关主题

期刊订阅